Showing 1421-1430 of 5954 results for "".
Making Hair Care Safer for Skin
https://practicaldermatology.com/series/c-suite-chats/making-hair-care-safer-for-skin/32711/Iris Rubin, Founder and Chief Medical Officer of SEEN, discusses how hair care products can cause a variety of skin issues, and the process in which she developed SEEN hair care.Skin Cancer Prevention: Can Laser Therapy Help?
https://practicaldermatology.com/conferences/scale-2023/skin-cancer-prevention-can-laser-therapy-help/20205/Non-ablative fractional laser treatments may dramatically the reduce risk of skin cancer recurrence. Joel L. Cohen, MD, and Mathew M. Avram, MD, JD, discuss the science behind this intriguing finding.The Current Armamentarium of Topical Therapies to Treat Atopic Dermatitis and Psoriasis
https://practicaldermatology.com/topics/atopic-dermatitis/the-current-armamentarium-of-topical-therapies-to-treat-atopic-dermatitis-and-psoriasis/23748/A review of the alternatives to topical corticosteroids for managing common inflammatory skin diseases.Rosacea Update: A Closer Look at Zilxi
https://practicaldermatology.com/columns/clinical-focus-1/rosacea-update-a-closer-look-at-zilxi/23339/Inside the approval of Zilxi for moderate-to-severe facial papulopustular rosacea.New Advancements in Microneedle Resurfacing
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-advancements-in-microneedle-resurfacing/21354/Microneedle resurfacing has quickly become one of the most in-demand aesthetic procedures, likely due to its strong results, quick healing times, and cost-effectiveness.New FDA Approval for AD
https://practicaldermatology.com/series/c-suite-chats/new-fda-approval-for-ad/29911/Phil Brown, MD, JD, Dermatologic Scientific Lead at Organon, talks about the importance of a new FDA-approved topical solution for treating atopic dermatitis.Evolving Perspectives: The Dermatology M&A Market in Today’s Environment
https://practicaldermatology.com/topics/practice-management/evolving-perspectives-the-dermatology-ma-market-in-todays-environment/23945/Halfway through 2023: The trends and emerging insights in the dermatology and aesthetics industries.Late-Stage Drugs for Atopic Dermatitis: An Update
https://practicaldermatology.com/topics/atopic-dermatitis/late-stage-drugs-for-atopic-dermatitis-an-update/23373/Here’s a look at investigational agents for this common disease.Breaking a Sweat: Treating Hyperhidrosis in the COVID-19 Era
https://practicaldermatology.com/series/dermatology-dispatches/breaking-a-sweat-treating-hyperhidrosis-in-the-covid-19-era/19767/Hyperhidrosis patients can be evaluated with telemedicine, says Neal Bhatia, MD. It’s important that these individuals have adequate supplies of their medication for the duration of any stay-at-home orders. In addition, dermatologists should try to distinguish between anxiety-induced sweating and prA Closer Look at Skyrizi
https://practicaldermatology.com/columns/clinical-focus-1/a-closer-look-at-skyrizi/23016/The newest IL-23 blocker for psoriasis may prove to be a blockbuster, according to analysts.